Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Synacthen Retard


Contraindicated
Lack of data in pregnant women

Not recommended
Use with caution
Synacthen Retard :
Type TAU
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Manufacturer Novartis Pharma AG
Origin Switzerland
ATC H01AA02
Revision Date 31/03/2004

Your comment will appear shortly after approval

Synacthen Retard :

Revision Date : 01/05/2012


Effect Frequency
Abdominal distension Not known
Abscess Not known
Acute kidney injury Very rare
Adrenal haemorrhage Very rare
Alkalosis hypochloraemic Not known
Amoebiasis Not known
Anaphylactic shock Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Aseptic necrosis Not known
Blood potassium decreased Not known
Calcium low Not known
Cardiac failure Not known
Cephalea Not known
Convulsion Not known
Cushing's syndrome Not known
Diabetes mellitus precipitated Not known
Dyspnoea (dyspnea) Not known
Ecchymosis Not known
Emotional lability Not known
Eruption acneiform Not known
Erythema facial Not known
Exophthalmos (Bulging eyes) Not known
Fluid retention Not known
Fracture Not known
Gastric haemorrhage Not known
Gastric perforation Not known
Gastric ulcer Not known
Glaucoma Not known
Glucose tolerance decreased Not known
Growth failure Not known
Hirsutism Not known
Hot flush Not known
Hyperglycaemia Not known
Hypersensitivity reactions Not known
Hypertension Not known
Impaired healing Not known
Increased appetite Not known
Infection susceptibility increased Not known
Injection site reaction Not known
Intracranial hypertension (Intracranial pressure increased) Not known
Intraocular pressure increased Not known
Leukocytosis Not known
Macular degeneration Not known
Malaise Not known
Menstruation irregular Not known
Muscle atrophy Not known
Muscle weakness Not known
Nausea Not known
Necrotizing angiitis Not known
Nitrogen balance negative Not known
Oesophagitis ulcerative Not known
Osteoporosis Not known
Pancreatitis Not known
Papilloedema Not known
Pathological fracture Not known
Petechiae Not known
Pigmentation disorder Not known
Posterior subcapsular cataract Not known
Pruritus Not known
Psychological disorder Not known
Skin test negative ( Not known
Skin thinning Not known
Sodium retention Not known
Steroid myopathy Not known
Sweating increased (Excessive sweating) (Hyperhydrosis) Not known
Tendon rupture Not known
Thromboembolism Not known
Tuberculosis Not known
Urticaria Not known
Vertigo Not known
Virilism Not known
Vomiting Not known
Weight increased (weight gain) Not known

Different Units By MoH Code

Synacthen Retard  MoH 2060845 :
Form Solution for injection
Packaging Ampoules
Package Size Box of 1
Strength 1mg
Stratum N/A
NSSF ✘
Quarantine ✘


Price Comparison

● Country: KSA
● Package Size: 1ml
● Public Price: 1698 SAR ( 40,140,720.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1698 SAR ( 40,140,720.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1
● Public Price: 10.07 EUR ( 975,541.32 LBP )
● Pack size unit used: 1
● Cost/Unit: 10,07 EUR ( 968,760.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1ml Ampoule
● Public Price: 29.5 AED ( 712,749.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 29,5 AED ( 700,669.00 LBP )
● Pharmacy Price: 23.81 AED ( 575273.41 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1ml Ampoule
● Public Price: 21.68 AED ( 523,810.48 LBP )
● Pack size unit used: 1
● Cost/Unit: 21,68 AED ( 507,381.00 LBP )
● Pharmacy Price: 18.85 AED ( 455434.85 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 1
● Public Price: 119.59 TRY ( 320,501.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 119,59 TRY ( 318,920.00 LBP )
● Pricing Date: 31/12/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info